Clinical Trial Update: A Proof of Concept Trial in Overweight and Obese Patients, Investigating Effect of EMP16-02 on Body Weight (Primary) [Phase 1, Phase 2]

View source ↗

Summary

A proof-of-concept study investigating EMP16-02 for body weight reduction in overweight and obese patients; completed Phase 1/2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• EMP16-02

Snippet

Sponsor: Empros Pharma AB | Conditions: Overweight or Obesity | Phase 1, Phase 2 | Status: COMPLETED